Bone marrow involvement in histiocytosis X.

Area of Science:

• Hematology
• Pediatric Oncology
• Pathology

Background:

• Histiocytosis X (HX), a rare disorder involving abnormal proliferation of histiocytes.
• Bone marrow involvement is a significant prognostic factor in HX.

Purpose of the Study:

• To investigate the prevalence and clinical significance of bone marrow involvement in patients diagnosed with Histiocytosis X.
• To determine if bone marrow involvement correlates with specific clinical features and patient outcomes.

Main Methods:

• Retrospective review of bone marrow aspirates and trephine biopsies from 28 patients with Histiocytosis X at diagnosis.
• Statistical analysis to compare clinical and laboratory findings between patients with and without bone marrow involvement.

Main Results:

• Bone marrow involvement was identified in 5 of 28 patients (18%).
• Patients with bone marrow involvement showed a higher frequency of fever, splenomegaly, rash, diabetes insipidus, and lower platelet counts.
• Two patients with bone marrow involvement died, compared to zero deaths in the other 23 patients.
• Trephine biopsy sections were more effective for diagnosing marrow HX than aspiration smears.

Conclusions:

• Bone marrow involvement at diagnosis in Histiocytosis X may indicate more extensive and potentially fatal disease.
• Early identification of bone marrow involvement through trephine biopsy can aid in risk stratification and management decisions.